Context Therapeutics Inc (CNTX) Financials

$0.37

$0.00 (-0.97%)

As on 10-Sep-2026 16:22EDT

Market cap

$33 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.07	0.12	0.05	0.01	0.01	--
Gross Profit	-0.07	-0.12	-0.05	-0.01	-0.01	--
Operating Expenses	48.72	39.70	29.92	25.07	15.38	10.53
Operating Profit (EBIT)	-48.73	-39.70	-29.92	-25.07	-15.38	-10.53
Other Income	--	--	--	--	--	--
Profit before Tax	-45.96	-36.12	-26.73	-23.96	-14.84	-10.46
Provision for Tax	--	--	--	0.00	-0.55	-3.02
Profit after Tax (Net Income)	-45.96	-36.12	-26.73	-23.96	-14.84	-10.46
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-10.46

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Shareholder's Funds	38.17	60.47	95.27	11.87	34.76	48.27
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.08	--	0.11	--	0.00	0.00
Current Liabilities	7.88	8.02	2.75	4.19	3.21	3.03
Total Liabilities	54.02	68.49	98.13	16.06	37.97	51.31

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.32	0.14	0.23	0.02	0.11	0.05
Current Assets	45.82	68.35	97.90	16.05	37.85	51.26
Total Assets	54.02	68.49	98.13	16.06	37.97	51.31
Total Debt*	0.24	0.11	0.22	--	0.06	--
Net Current Assets	37.93	60.33	95.15	11.86	34.65	48.22

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-26.39	-14.56	-21.05	-13.55	-8.80
Cash Flow from Investing Activities	--	-2.03	-14.76	--	-0.54	-0.25
Cash from Financing Activities	--	-0.02	109.29	--	-0.10	58.39
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.49	-0.39	-0.46	-1.50	-0.93	-1.02
Cash EPS ($)	--	-0.39	-0.46	-1.50	-0.93	-1.02
Adjusted Book Value ($)	--	0.66	1.63	0.74	2.18	4.73
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.29	-0.25	-1.32	-0.85	-0.86
Free Cash Flow per Share ($)	--	-0.29	-0.50	-1.32	-0.88	-0.89

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-46.29	-49.79	-102.66	-35.71	-56.06
ROE (%)	-93.18	-46.39	-49.89	-102.79	-35.74	-66.71
ROA (%)	-63.07	-43.36	-46.81	-88.71	-33.24	-40.40
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	8.21	-35.17	-11.52	-61.04	-100.07	-189.17
Net Profit Growth (%)	-34.35	-35.17	-11.52	-61.53	-41.88	-257.38
EPS Growth (%)	-17.53	0.14	0.70	-0.62	0.09	-2.57
Book Value Growth (%)	-53.75	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-3.74	-2.30	-0.75	-0.70	-2.60
Price / Book Value	0.87	2.23	0.64	1.52	0.30	0.56
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.60	-1.92	1.23	-0.15	1.68	2.14
Close Price ($)	0.55	1.47	1.05	1.13	0.65	2.66
High Price ($)	3.62	1.55	2.75	1.69	2.83	252.00
Low Price ($)	0.55	0.49	0.89	0.47	0.60	2.56
Market Cap ($ Cr)	33.23	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.00	0.00	--	0.00	--
Short term debt to equity ratio	0.00	0.00	0.00	--	0.00	--
Current Ratio	5.81	8.52	35.62	3.83	11.80	16.90
Quick Ratio	5.81	--	--	--	--	--
Interest Coverage	--	--	--	--	-27.19	-115.78

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	5,838.21	13,289.64	50,331.75	54,437.23	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.